# Contact Peptides For Doctors — Editorial Desk

> Reach the Peptides For Doctors editorial desk regarding citations, corrections, or research-related correspondence about our Growth Hormone Axis peptide digest.

Correspondence on citations, corrections, and research-related inquiries — the things a reference desk most wants to hear.

## Editorial correspondence

Peptides For Doctors welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study on Sermorelin, Tesamorelin, or CJC-1295 that should be added to the [references page](/references). Corrections that improve accuracy are the most useful messages we receive, and they are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible.

**Editorial mailbox:** editors@peptidesfordoctors.com

## What this desk cannot do

To prevent any message going unanswered for the wrong reason, the following fall outside what this site can address. Peptides For Doctors is a literature digest, not a clinic or a vendor, so we cannot:

- Advise on, recommend, or comment on human use of any peptide discussed here.
- Suggest a dose, schedule, or route of administration for any individual.
- Diagnose a condition or judge whether a particular research finding applies to a particular person.
- Sell, source, recommend, or help locate any compound from any supplier.
- Advise athletes on anti-doping matters, given that GHRH analogs are prohibited in sport under WADA S2.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.

---

A clinician-facing literature digest — what the research says, stated precisely, with citations and without advice.
